https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-09-24 / Int J Hyperthermia 2012;28(8):707-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-09-24 / Int J Hyperthermia 2012;28(8):707-142012-09-24 00:00:002019-02-15 08:39:16Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-07-31 / Br J Anaesth 2012 Nov;109(5):754-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-07-31 / Br J Anaesth 2012 Nov;109(5):754-612012-07-31 00:00:002019-02-15 08:39:15Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-05-01 / J. Cell. Biochem. 2012 May;113(5):1547-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-05-01 / J. Cell. Biochem. 2012 May;113(5):1547-582012-05-01 00:00:002019-02-15 08:39:18Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-01-03 / Scand. J. Gastroenterol. 2012 Mar;47(3):315-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-01-03 / Scand. J. Gastroenterol. 2012 Mar;47(3):315-242012-01-03 00:00:002019-02-15 08:46:00Immunotherapy for metastatic colorectal cancer: present status and new options
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-01 / Anticancer Res. 2011 Nov;31(11):3963-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-01 / Anticancer Res. 2011 Nov;31(11):3963-72011-11-01 00:00:002019-02-15 08:39:19Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-01 / Anticancer Res. 2011 Nov;31(11):3995-4005
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-01 / Anticancer Res. 2011 Nov;31(11):3995-40052011-11-01 00:00:002019-02-15 08:46:01Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-10-15 / Immunopharmacol Immunotoxicol 2012 Jun;34(3):465-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-10-15 / Immunopharmacol Immunotoxicol 2012 Jun;34(3):465-92011-10-15 00:00:002019-02-15 08:46:01Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 2533)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 2533)2011-06-04 00:00:002011-06-04 00:00:00A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 3557)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 3557)2011-06-04 00:00:002011-06-04 00:00:00Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-01 / Anticancer Res. 2010 Dec;30(12):5091-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-01 / Anticancer Res. 2010 Dec;30(12):5091-72010-12-01 00:00:002019-02-15 08:46:02Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients
